Protection offered by SARS coronavirus 2 vaccines against disease and infection.

Griffiths, Paul D

Griffiths, Paul D.

Griffiths PD; Institute for Immunity and Transplantation, University College Medical School, London, UK.

Rev Med Virol ; 32(1): e2303, 2022 01.

Article in English | MEDLINE | ID: covidwho-1453657

Subject(s)

COVID-19; Severe Acute Respiratory Syndrome; COVID-19 Vaccines; Humans; SARS-CoV-2; Severe Acute Respiratory Syndrome/epidemiology; Severe Acute Respiratory Syndrome/prevention & control; Spike Glycoprotein, Coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Rev Med Virol Journal subject: Virology Year: 2022 Document Type: Article Affiliation country: Rmv.2303

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google